Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 421: Dexmedetomidine is a

A. Centrally acting alpha 2 agonist (Correct Answer)
B. Peripherally acting alpha2 agonist
C. Centrally acting alpha 2 antagonist
D. Peripherally acting alpha 2 antagonist

Explanation: **Explanation:** **Dexmedetomidine** is a highly selective **alpha-2 ($\alpha_2$) adrenergic agonist**. Its primary site of action is the **Locus Coeruleus** in the brainstem (pons). By stimulating central $\alpha_2$ receptors, it inhibits the release of norepinephrine, leading to a state of "conscious sedation" and analgesia. * **Why Option A is Correct:** Dexmedetomidine acts **centrally** on $\alpha_2$ receptors. Unlike Clonidine, it is 8 to 10 times more selective for the $\alpha_2$ receptor, making it a potent sedative and anesthetic adjuvant. It produces sedation that mimics natural sleep, where patients remain easily arousable. * **Why Options B & D are Incorrect:** While $\alpha_2$ receptors exist peripherally (causing transient initial vasoconstriction), the therapeutic effects of Dexmedetomidine (sedation, sympatholysis, and bradycardia) are mediated through the **Central Nervous System (CNS)**. It is not an antagonist; an example of an $\alpha_2$ antagonist is Yohimbine. * **Why Option C is Incorrect:** Dexmedetomidine is an **agonist**, not an antagonist. Antagonists would block the receptor and typically increase sympathetic outflow. **High-Yield Clinical Pearls for NEET-PG:** 1. **Unique Property:** It causes **"Conscious Sedation"**—the patient is sedated but can be easily awakened to follow commands. 2. **Respiratory Safety:** Unlike opioids or benzodiazepines, it causes **minimal respiratory depression**, making it ideal for ICU sedation and awake intubation. 3. **Side Effects:** The most common side effects are **bradycardia** and **hypotension** due to decreased central sympathetic outflow. 4. **Clinical Use:** Used for short-term ICU sedation, premedication, and as an adjunct in spinal/epidural anesthesia to prolong the block duration.

Question 422: What is the mechanism of action of oximes?

A. Inhibiting cholinergic receptors
B. Reactivating cholinesterase (Correct Answer)
C. Inhibiting cholinesterase
D. Reactivating cholinergic receptors

Explanation: **Explanation:** **Mechanism of Action:** Oximes (such as **Pralidoxime/2-PAM** and Obidoxime) are known as **cholinesterase reactivators** [1], [3]. In organophosphate (OP) poisoning, the organophosphate compound binds to the esteratic site of the acetylcholinesterase (AChE) enzyme, phosphorylating it and rendering it inactive. This leads to an accumulation of acetylcholine. Oximes have a high affinity for the phosphorus atom; they bind to the OP-enzyme complex, nucleophilically attack the phosphate bond, and pull the phosphate group away, thereby freeing and **reactivating the cholinesterase enzyme** [1], [3]. **Analysis of Options:** * **Option A & D:** Oximes do not act directly on cholinergic receptors (nicotinic or muscarinic). Their primary target is the enzyme itself. * **Option C:** Inhibiting cholinesterase is the mechanism of the poison (Organophosphates/Carbamates), not the antidote. **High-Yield Clinical Pearls for NEET-PG:** 1. **The "Aging" Phenomenon:** Oximes must be administered early. If the OP-enzyme bond "ages" (dealkylation), the bond becomes permanent, and oximes can no longer reactivate the enzyme [2], [3]. 2. **Blood-Brain Barrier:** Pralidoxime is a quaternary ammonium compound and **does not cross the BBB**. Therefore, it does not reverse central CNS symptoms (Atropine is required for this). 3. **Specific Contraindication:** Oximes are generally **not recommended in Carbamate poisoning** (e.g., Neostigmine, Physostigmine) because the carbamoyl-enzyme complex dissociates quickly on its own, and oximes may actually worsen the inhibition. 4. **Clinical Use:** They are specifically effective against the **nicotinic effects** (muscle fasciculations and paralysis) of OP poisoning, whereas Atropine handles the muscarinic effects.

Question 423: Which one of the following neurotransmitters acts commonly on both the parasympathetic and sympathetic divisions of the autonomic nervous system?

A. Atropine
B. Pilocarpine
C. Acetylcholine (Correct Answer)
D. Adrenaline

Explanation: ### Explanation **Correct Answer: C. Acetylcholine** **Why it is correct:** Acetylcholine (ACh) is the primary neurotransmitter that bridges both divisions of the Autonomic Nervous System (ANS). It acts at three key sites across both systems: 1. **Preganglionic Neurons:** ACh is the neurotransmitter for all preganglionic fibers in both the sympathetic and parasympathetic nervous systems, acting on **Nicotinic (Nn)** receptors in the ganglia. 2. **Parasympathetic Postganglionic Neurons:** It acts on **Muscarinic** receptors at the effector organs. 3. **Sympathetic Exceptions:** ACh is also the neurotransmitter for sympathetic postganglionic fibers supplying **sweat glands** (thermoregulatory) and some blood vessels in skeletal muscles. **Why the other options are incorrect:** * **A. Atropine:** This is not a neurotransmitter; it is a competitive **muscarinic antagonist** (drug) used to block parasympathetic effects. * **B. Pilocarpine:** This is a **muscarinic agonist** (cholinomimetic drug), not an endogenous neurotransmitter. It is primarily used in the treatment of glaucoma and xerostomia. * **D. Adrenaline (Epinephrine):** While it is a neurotransmitter/hormone, it acts almost exclusively on the **sympathetic** division (Adrenergic receptors). It has no physiological role in the parasympathetic ganglia or postganglionic terminals. **NEET-PG High-Yield Pearls:** * **The "All-Preganglionic" Rule:** Remember that *all* autonomic preganglionic fibers (Sympathetic + Parasympathetic) and the fibers to the **Adrenal Medulla** are cholinergic. * **Somatic Nervous System:** ACh is also the neurotransmitter at the Neuromuscular Junction (NMJ), acting on **Nm** receptors. * **Sweat Glands Exception:** This is a favorite "catch" in exams—sweat glands are anatomically sympathetic but pharmacologically cholinergic.

Question 424: Botulinum toxin acts by:

A. Synthesis of acetylcholine.
B. Inhibiting acetylcholine release. (Correct Answer)
C. Secretion of acetylcholine.
D. None of the above.

Explanation: Explanation: **Mechanism of Action:** Botulinum toxin, produced by the bacterium *Clostridium botulinum*, is a potent neurotoxin that causes flaccid paralysis [2]. It acts presynaptically at the neuromuscular junction [4]. The toxin is a protease that cleaves **SNARE proteins** (specifically SNAP-25, synaptobrevin, or syntaxin), which are essential for the fusion of acetylcholine (ACh) vesicles with the neuronal membrane. By preventing this fusion, the toxin effectively **inhibits the release of acetylcholine** into the synaptic cleft [2], [4]. **Analysis of Options:** * **Option A (Incorrect):** The synthesis of ACh (mediated by Choline Acetyltransferase) is not affected by Botulinum toxin. Hemicholinium is a drug that interferes with synthesis by blocking choline uptake [1], [3]. * **Option C (Incorrect):** The toxin prevents secretion/release rather than promoting it. Drugs like Black Widow Spider Venom (alpha-latrotoxin) cause the massive *release* of ACh. * **Option D (Incorrect):** Option B is the established mechanism. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Uses:** Used for focal dystonias (Blepharospasm, Torticollis), Achalasia cardia, Hyperhidrosis (excessive sweating), and cosmetic reduction of wrinkles. * **Botulism:** Food-borne botulism (ingestion of preformed toxin) or Infant botulism (ingestion of spores from honey, known as "Floppy Baby Syndrome"). * **Antidote:** Guanidine or 4-Aminopyridine can sometimes be used to increase ACh release, but treatment is primarily supportive with antitoxin. * **Contrast:** Unlike Botulinum, **Tetanus toxin** (which also cleaves SNARE proteins) travels retrogradely to the CNS to inhibit GABA/Glycine release, leading to spastic paralysis [2].

Question 425: What is the drug of choice for poisoning with Amanita muscaria?

A. Atropine
B. Physostigmine
C. Diazepam (Correct Answer)
D. Pencillin

Explanation: **Explanation:** The drug of choice for *Amanita muscaria* poisoning is **Diazepam**. Contrary to popular belief, *Amanita muscaria* (Fly Agaric) does not primarily cause a "muscarinic" syndrome. Its main toxins are **ibotenic acid** and **muscimol**, which act on the Central Nervous System (CNS). Ibotenic acid acts as an NMDA agonist (excitatory), while muscimol is a potent GABA-A agonist. This leads to a "pantherina syndrome" characterized by delirium, hallucinations, muscle jerks, and seizures. **Diazepam** is the treatment of choice to manage these CNS excitations, seizures, and agitation [1]. **Analysis of Incorrect Options:** * **Atropine:** While the mushroom is named *Amanita muscaria*, it contains negligible amounts of muscarine. Atropine is generally **contraindicated** because it can worsen the delirium and central anticholinergic-like symptoms often seen in these patients [2]. * **Physostigmine:** This is used for anticholinergic poisoning (e.g., *Datura*). In *Amanita muscaria* poisoning, it would exacerbate the condition and increase the risk of seizures. * **Penicillin:** High-dose Penicillin G is used in the treatment of ***Amanita phalloides*** (Death Cap) poisoning to inhibit the uptake of amatoxins by hepatocytes, but it has no role in *Amanita muscaria* toxicity. **Clinical Pearls for NEET-PG:** 1. **Amanita muscaria:** Think CNS symptoms (Delirium/Seizures) → Treat with **Benzodiazepines (Diazepam)** [1]. 2. **Inocybe/Clitocybe species:** These contain high muscarine levels → Treat with **Atropine** [2]. 3. **Amanita phalloides:** Causes hepatic failure (Amatoxins) → Treat with **Silibinin** or **Penicillin G**. 4. Avoid Atropine in *A. muscaria* unless clear, life-threatening cholinergic signs (bradycardia, SLUDGE) are present, which is rare [2].

Question 426: Which of the following antagonizes the visceral side effects of neostigmine used in the reversal of d-tubocurarine blockade?

A. Atropine (Correct Answer)
B. Nicotine
C. Pilocarpine
D. Pyridostigmine

Explanation: **Explanation:** **1. Why Atropine is the Correct Answer:** Neostigmine is an acetylcholinesterase inhibitor used to reverse the neuromuscular blockade caused by non-depolarizing agents like d-tubocurarine. By inhibiting the breakdown of acetylcholine (ACh), it increases ACh levels at both **nicotinic** and **muscarinic** receptors. While the action at nicotinic receptors (NMJ) restores muscle power, the action at muscarinic receptors causes unwanted **visceral side effects** (parasympathetic overactivity) such as bradycardia, excessive salivation, bronchospasm, and increased GI motility. **Atropine**, a muscarinic antagonist, is co-administered to selectively block these visceral effects without interfering with the desired nicotinic action at the skeletal muscles. **2. Why Other Options are Incorrect:** * **Nicotine:** This is a nicotinic agonist. It would not antagonize the muscarinic side effects and could potentially worsen autonomic instability. * **Pilocarpine:** This is a muscarinic agonist. It would exacerbate the side effects of neostigmine (e.g., further increasing secretions and bradycardia). * **Pyridostigmine:** This is another acetylcholinesterase inhibitor (similar to neostigmine). It would worsen the cholinergic crisis rather than antagonizing the side effects. **3. High-Yield Clinical Pearls for NEET-PG:** * **Glycopyrrolate** is often preferred over Atropine in clinical practice because it is polar (does not cross the blood-brain barrier) and has a heart rate matching profile closer to neostigmine. * **Neostigmine** is preferred over Physostigmine for reversal because it has a stronger action on the NMJ and does not cross the BBB. * **Rule of Thumb:** Always pair an anticholinesterase (Neostigmine) with an anticholinergic (Atropine/Glycopyrrolate) to prevent "vagal arrest" during anesthesia reversal.

Question 427: The fall in blood pressure caused by d-tubocurarine is due to:

A. Reduced venous return
B. Ganglionic blockade
C. Histamine release
D. All of the above (Correct Answer)

Explanation: **Explanation:** d-Tubocurarine (d-TC) is a prototype non-depolarizing neuromuscular blocker that causes a significant fall in blood pressure through three primary mechanisms: 1. **Ganglionic Blockade:** d-TC has a high affinity for nicotinic receptors ($N_n$) at the autonomic ganglia. By blocking these receptors, it inhibits sympathetic outflow to the blood vessels, leading to vasodilation and a subsequent drop in blood pressure. 2. **Histamine Release:** d-TC is a potent inducer of mast cell degranulation. The sudden release of histamine causes systemic vasodilation and increased capillary permeability, further contributing to hypotension and potentially causing bronchospasm. 3. **Reduced Venous Return:** The drug causes profound skeletal muscle relaxation. The loss of the "skeletal muscle pump" (which normally aids in pushing blood back to the heart) results in peripheral pooling of blood and decreased venous return, leading to a fall in cardiac output and blood pressure. **Why "All of the above" is correct:** Since d-TC simultaneously triggers ganglionic blockade, histamine release, and a reduction in venous return, all three physiological factors synergistically contribute to the observed hypotension. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for intubation:** Succinylcholine (fastest onset) or Rocuronium (best safety profile). * **Hofmann Elimination:** Atracurium and Cisatracurium undergo spontaneous non-enzymatic degradation, making them safe in liver and kidney failure. * **Mivacurium:** The shortest-acting non-depolarizing blocker, metabolized by plasma cholinesterase. * **Reversal:** Neostigmine (with Glycopyrrolate) or Sugammadex (specifically for Rocuronium/Vecuronium).

Question 428: Cholinomimetics are useful in all the following conditions except?

A. Glaucoma
B. Myasthenia gravis
C. Postoperative atony of bladder
D. Partial heart block (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Partial heart block** **Mechanism & Rationale:** Cholinomimetics (cholinergic agonists) mimic the action of acetylcholine. In the heart, acetylcholine acts on **M2 receptors** located primarily in the SA and AV nodes. Activation of these receptors leads to: 1. **Negative chronotropy:** Decreased heart rate. 2. **Negative dromotropy:** Decreased conduction velocity through the AV node. In a patient with **partial heart block**, the conduction through the AV node is already impaired. Administering a cholinomimetic would further depress AV conduction, potentially converting a partial block into a **complete (third-degree) heart block** or causing cardiac arrest. Therefore, cholinomimetics are strictly contraindicated in conduction abnormalities. **Analysis of Incorrect Options:** * **A. Glaucoma:** Cholinomimetics (e.g., Pilocarpine) cause contraction of the ciliary muscle and sphincter pupillae (miosis). This opens the trabecular meshwork and the canal of Schlemm, facilitating the drainage of aqueous humor and reducing intraocular pressure. * **B. Myasthenia gravis:** Acetylcholinesterase inhibitors (e.g., Neostigmine, Pyridostigmine) prevent the breakdown of endogenous acetylcholine at the neuromuscular junction, increasing its availability to stimulate the remaining nicotinic receptors, thereby improving muscle strength. * **C. Postoperative atony of bladder:** Cholinomimetics (e.g., Bethanechol) stimulate **M3 receptors** on the detrusor muscle, causing it to contract and promoting voiding in non-obstructive urinary retention. **High-Yield Clinical Pearls for NEET-PG:** * **Contraindications of Cholinomimetics:** Bronchial asthma (causes bronchoconstriction), Peptic ulcer (increases gastric acid), and Mechanical obstruction of the gut/bladder. * **Drug of Choice (DOC):** Pyridostigmine is the DOC for long-term management of Myasthenia Gravis. * **Bethanechol** is the preferred agent for postoperative urinary retention because it has negligible nicotinic and cardiovascular effects.

Question 429: Which of the following is a short-acting anticholinesterase?

A. Physostigmine
B. Neostigmine
C. Edrophonium (Correct Answer)
D. Rivastigmine

Explanation: **Explanation:** The correct answer is **Edrophonium**. Anticholinesterases are classified based on the nature of their binding to the acetylcholinesterase (AChE) enzyme. 1. **Why Edrophonium is correct:** Edrophonium is a quaternary ammonium compound that binds only to the **anionic site** of the enzyme via weak hydrogen bonds [1]. Because it does not form a covalent bond, it is rapidly eliminated by the kidneys [1]. It has an extremely short duration of action (**5–15 minutes**), making it the drug of choice for the **Tensilon Test** (used to differentiate between a myasthenic crisis and a cholinergic crisis). 2. **Why the other options are incorrect:** * **Physostigmine & Neostigmine:** These are carbamates that form a covalent bond at the **esteratic site** of the enzyme [1]. They are classified as **intermediate-acting** anticholinesterases, with a duration of action typically ranging from 30 minutes to 6 hours [2]. * **Rivastigmine:** This is a lipid-soluble carbamate used primarily in Alzheimer’s disease. It is also intermediate-acting but has a relatively long "pseudo-irreversible" effect on the CNS. **High-Yield Clinical Pearls for NEET-PG:** * **Tensilon Test:** If symptoms improve after Edrophonium, it is a **Myasthenic crisis** (under-dosage). If symptoms worsen, it is a **Cholinergic crisis** (over-dosage). * **Physostigmine** is the only clinically used tertiary amine (crosses BBB) and is the antidote for **Atropine poisoning** [2]. * **Neostigmine** is the preferred agent for reversing neuromuscular blockade (non-depolarizing muscle relaxants) and treating Myasthenia Gravis.

Question 430: All of the following statements about clonidine are true EXCEPT:

A. It is an alpha-adrenergic agonist
B. It can cause dry mouth as an adverse effect
C. Prazosin completely antagonizes its action (Correct Answer)
D. It inhibits sympathetic outflow

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The False Statement):** Clonidine is a selective **$\alpha_2$-adrenergic agonist**. Its primary mechanism of action involves stimulating presynaptic $\alpha_2$ receptors in the nucleus tractus solitarius (NTS), which reduces sympathetic outflow. **Prazosin**, on the other hand, is a selective **$\alpha_1$-blocker**. Since they act on different receptor subtypes ($\alpha_2$ vs. $\alpha_1$), Prazosin does not antagonize the central antihypertensive effects of clonidine. The drug that can antagonize clonidine is **Yohimbine** (a selective $\alpha_2$-blocker). **2. Analysis of Incorrect Options (True Statements):** * **Option A:** Clonidine is indeed an **$\alpha$-adrenergic agonist**, specifically selective for the $\alpha_2$ subtype. * **Option B:** **Dry mouth (xerostomia)** and sedation are the two most common side effects of clonidine due to its central action and reduction of salivary secretions. * **Option D:** By stimulating central $\alpha_2$ receptors, clonidine **inhibits sympathetic outflow** from the vasomotor center in the medulla, leading to a decrease in blood pressure and heart rate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rebound Hypertension:** Sudden withdrawal of clonidine can cause a hypertensive crisis due to a massive surge in catecholamines. This is managed by restarting clonidine or using **Phentolamine** (non-selective $\alpha$-blocker). * **Other Uses:** Apart from hypertension, clonidine is used in opioid withdrawal, ADHD, Tourette syndrome, and prophylaxis of migraine. * **Diagnostic Test:** The **Clonidine Suppression Test** is used to diagnose Pheochromocytoma (clonidine fails to suppress plasma catecholamines in these patients).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free